<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161292">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01708395</url>
  </required_header>
  <id_info>
    <org_study_id>REMICADEIBD4007</org_study_id>
    <nct_id>NCT01708395</nct_id>
  </id_info>
  <brief_title>IBD-OPERA Database, UC Protocol</brief_title>
  <acronym>OPERA</acronym>
  <official_title>IBD-OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Janssen Services, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators believe that patients with ulcerative colitis are able to report details
      of their own medical history accurately and record changes in clinical status effectively
      over time.  Using an internet-based database the investigators will ask patients to report
      their own disease history, and the investigators will compare their reports to the medical
      record.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Validity of patient self reporting</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The validity of patient self report on details of their ulcerative colitis compared to chart review. Validity is defined as a match between patient self report and medical records.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Inflammatory Bowel Disease</condition>
  <arm_group>
    <arm_group_label>Cohort 1</arm_group_label>
    <description>First 50 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2</arm_group_label>
    <description>2nd group of 50 patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults over 18 years of age
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  MD documented diagnosis of ulcerative colitis

          -  current of past prescription for anti-TNF medication

          -  at least 18 years of age

          -  access to medical records to verify information

          -  20% of participants will be patients diagnosed within 1 year of inclusion

        Exclusion Criteria:

          -  unwilling or unable to provide informed consent for study participation

          -  unable to access or use internet

          -  less than 18 years of age

          -  diagnosis of crohn's disease or IBD-U

          -  illiterate or does not possess minimum level of literacy required to complete
             questionnaire
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jennifer Greene, RN</last_name>
    <email>jennifer.greene@bridgeibd.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Corey Siegel, MD</last_name>
    <phone>603-650-8101</phone>
    <email>corey.a.siegel@hitchcock.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corey A Siegel, MD</last_name>
      <phone>603-650-4481</phone>
      <email>corey.a.siegel@hitchcock.org</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer A Greene, RN</last_name>
      <phone>434-982-0709</phone>
      <email>jennifer.greene@bridgeibd.com</email>
    </contact_backup>
    <investigator>
      <last_name>Corey A Siegel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 5, 2014</lastchanged_date>
  <firstreceived_date>October 15, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ulcerative colitis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
